Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed · Phase 3

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacerbation and the proportion of patients hospitalized for an exacerbation during a six month observation period.

Key facts

Study ID

NCT00274547

Run by

Boehringer Ingelheim

People needed

1829

Starts

2001-09-01

Last updated by the study team

2013-11-01

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Boehringer Ingelheim Investigational Site — Birmingham, Alabama, United States
• Carl T. Hayden VA Medical Center — Phoenix, Arizona, United States
• Southern Arizona VA Health Care System — Tuscon, Arizona, United States
• VA Long Beach Healthcare System — Long Beach, California, United States
• Boehringer Ingelheim Investigational Site — Palo Alto, California, United States
• Respiratory Diseases (111A) — Bay Pines, Florida, United States
• J. Hillis Miller Health Center — Gainesville, Florida, United States
• Veteran Affairs Medical Center — Hines, Illinois, United States
• Veterans Affairs Medical Center — North Chicago, Illinois, United States
• Boehringer Ingelheim Investigational Site — Indianapolis, Indiana, United States
• Boehringer Ingelheim Investigational Site — Lexington, Kentucky, United States
• 4720 I-10 Service Road — Metairie, Louisiana, United States
• Boehringer Ingelheim Investigational Site — Boston, Massachusetts, United States
• Veteran Affairs Medical Center — Minneapolis, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Kansas City, Missouri, United States
• Boehringer Ingelheim Investigational Site — Omaha, Nebraska, United States
• Boehringer Ingelheim Investigational Site — Reno, Nevada, United States
• Boehringer Ingelheim Investigational Site — Buffalo, New York, United States
• Bronx VA Medical Center — New York, New York, United States
• Boehringer Ingelheim Investigational Site — Durham, North Carolina, United States
• Dallas VAMC — Dallas, Texas, United States
• Veterans Affairs Medical Center — Houston, Texas, United States
• Boehringer Ingelheim Investigational Site — San Antonio, Texas, United States
• Boehringer Ingelheim Investigational Site — Salt Lake City, Utah, United States
• Hampton VA Medical Center — Hampton, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.